Literature DB >> 21569042

Knops blood group polymorphism and susceptibility to Mycobacterium tuberculosis infection.

Ghislain T Noumsi1, Anatole Tounkara, Hama Diallo, Katrina Billingsley, John J Moulds, Joann M Moulds.   

Abstract

BACKGROUND: Complement receptor 1 (CR1) protein carries the Knops blood group antigens and is the receptor for the major ligand involved in Mycobacterium tuberculosis (Mtb) adhesion to macrophages. Erythrocyte CR1 binds immune complexes (ICs) formed during Mtb invasion, facilitating their clearance by the host immune system. The occurrence of specific Knops blood group genotypes among African populations was investigated to evaluate their impact on resistance or susceptibility to Mtb infection. STUDY DESIGN AND METHODS: The distribution of the Knops blood group genotypes (McC and Sl) was compared between tuberculosis (TB) patients with confirmed diagnosis of Mtb in isolates and negative controls. Conditional logistic regression was used to access the association between genotypes distribution and susceptibility to Mtb infection.
RESULTS: At the McC locus, individuals heterozygous (McC(a) /McC(b) ) were more resistant to Mtb infection (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.22-0.81; p = 0.007). Although less significant, a similar effect was conferred by Sl1/Sl2 genotype (OR, 0.05; 95% CI, 0.28-0.9; p = 0.02). This protective effect was maintained among individuals presenting the McC(b) /Sl2 haplotype (OR, 0.25; 95% CI, 0.08-0.74; p = 0.008).
CONCLUSION: Acquisition of McC(b) and Sl2 alleles among African population is correlated with resistance to Mtb infection, adding this bacterium to the list of mechanisms underlying the selection of the Knops blood group polymorphism among these populations.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569042     DOI: 10.1111/j.1537-2995.2011.03161.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  12 in total

Review 1.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

2.  Extensive genomic variability of knops blood group polymorphisms is associated with sickle cell disease in Africa.

Authors:  Kimberley C Duru; Jenelle A Noble; Aldiouma Guindo; Li Yi; Ikhide G Imumorin; Dapa A Diallo; Bolaji N Thomas
Journal:  Evol Bioinform Online       Date:  2015-03-09       Impact factor: 1.625

Review 3.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum.

Authors:  K M Dupnik; J M Bean; M H Lee; M A Jean Juste; L Skrabanek; V Rivera; C K Vorkas; J W Pape; D W Fitzgerald; M Glickman
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

5.  Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria.

Authors:  Patience B Tetteh-Quarcoo; Christoph Q Schmidt; Wai-Hong Tham; Richard Hauhart; Haydyn D T Mertens; Arthur Rowe; John P Atkinson; Alan F Cowman; J Alexandra Rowe; Paul N Barlow
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

6.  Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana.

Authors:  Helle H Hansson; Jørgen A Kurtzhals; Bamenla Q Goka; Onike P Rodriques; Francis N Nkrumah; Thor G Theander; Ib Christian Bygbjerg; Michael Alifrangis
Journal:  Malar J       Date:  2013-11-07       Impact factor: 2.979

7.  Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease.

Authors:  Thaisa Lucas Sandri; Kárita Cláudia Freitas Lidani; Fabiana Antunes Andrade; Christian G Meyer; Peter G Kremsner; Iara J de Messias-Reason; Thirumalaisamy P Velavan
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

8.  Geographical distribution of complement receptor type 1 variants and their associated disease risk.

Authors:  Thaisa Lucas Sandri; Selorme Adukpo; Dao Phuong Giang; Christian N Nguetse; Fabiana Antunes Andrade; Hoang van Tong; Nguyen Linh Toan; Le Huu Song; Preetham Elumalai; Kumarasamy Thangaraj; Vijaya Lakshmi Valluri; Francine Ntoumi; Christian G Meyer; Iara Jose de Messias Reason; Peter G Kremsner; Thirumalaisamy P Velavan
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

9.  Interethnic diversity of the CD209 (rs4804803) gene promoter polymorphism in African but not American sickle cell disease.

Authors:  Jenelle A Noble; Kimberley C Duru; Aldiouma Guindo; Li Yi; Ikhide G Imumorin; Dapa A Diallo; Bolaji N Thomas
Journal:  PeerJ       Date:  2015-02-24       Impact factor: 2.984

10.  Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.

Authors:  D H Opi; S Uyoga; E N Orori; T N Williams; J A Rowe
Journal:  Genes Immun       Date:  2016-02-04       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.